We are live on ! Find out more
William Blair & Company

William Blair & Company Portfolio holdings

AUM $34.9B
1-Year Est. Return 18.88%
This Fund
S&P 500
This Quarter Est. Return
-0.37%
1 Year Est. Return
+18.88%
3 Year Est. Return
+73.84%
5 Year Est. Return
+90.13%
10 Year Est. Return
+512.03%
AUM
$58.5B
AUM Growth
-$2.78B
Cap. Flow
-$639M
Cap. Flow %
-1.09%
Top 10 Hldgs %
6.82%
Holding
2,314
New
217
Increased
799
Reduced
860
Closed
188

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$246M
2
MNST icon
Monster Beverage
MNST
+$169M
3
BABA icon
Alibaba
BABA
+$103M
4
VRSK icon
Verisk Analytics
VRSK
+$100M
5
BIDU icon
Baidu
BIDU
+$86.1M

Sector Composition

Rank Sector Weight
1 Industrials 8.42%
2 Healthcare 6.73%
3 Technology 6.16%
4 Financials 5.99%
5 Consumer Discretionary 5.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DAL icon
1226
Delta Air Lines
DAL
$62.2B
$247K ﹤0.01%
+6,857
New +$262K
ERF
1227
DELISTED
Enerplus Corporation
ERF
$246K ﹤0.01%
13,000
-96
-0.7% -$2.1K
BHI
1228
DELISTED
Baker Hughes
BHI
$246K ﹤0.01%
3,794
+886
+30% +$61.8K
RF icon
1229
Regions Financial
RF
$27.4B
$245K ﹤0.01%
24,435
+839
+4% +$8.56K
IVW icon
1230
iShares S&P 500 Growth ETF
IVW
$77.9B
$244K ﹤0.01%
9,168
PBT
1231
Permian Basin Royalty Trust
PBT
$1.51B
$244K ﹤0.01%
18,000
+6,250
+53% +$87.7K
CMP icon
1232
Compass Minerals
CMP
$1.26B
$243K ﹤0.01%
2,883
-200
-6% -$17.9K
FUN icon
1233
Cedar Fair
FUN
$1.86B
$241K ﹤0.01%
5,105
EW icon
1234
Edwards Lifesciences
EW
$52B
$240K ﹤0.01%
14,142
-3,150
-18% -$49.7K
CACC icon
1235
Credit Acceptance
CACC
$6.37B
$239K ﹤0.01%
1,900
HUM icon
1236
Humana
HUM
$43.5B
$239K ﹤0.01%
1,842
+5
+0.3% +$635
IYE icon
1237
iShares US Energy ETF
IYE
$1.71B
$239K ﹤0.01%
4,654
-181
-4% -$9.96K
AB icon
1238
AllianceBernstein
AB
$3.48B
$238K ﹤0.01%
9,166
-4,600
-33% -$123K
ARIA
1239
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$236K ﹤0.01%
43,685
+24,980
+134% +$146K
KBR icon
1240
KBR
KBR
$4.68B
$233K ﹤0.01%
12,380
USD icon
1241
ProShares Ultra Semiconductors
USD
$2.88B
$232K ﹤0.01%
268,800
SSO icon
1242
ProShares Ultra S&P500
SSO
$8.39B
$229K ﹤0.01%
31,200
-2,400
-7% -$17.7K
DEW icon
1243
WisdomTree Global High Dividend Fund
DEW
$155M
$228K ﹤0.01%
4,926
-100
-2% -$4.88K
BCPC
1244
Balchem Corp
BCPC
$5.54B
$228K ﹤0.01%
4,027
-488
-11% -$26K
MBTF
1245
DELISTED
MBT Financial Corporation
MBTF
$228K ﹤0.01%
47,896
DAKT icon
1246
Daktronics
DAKT
$1.04B
$227K ﹤0.01%
18,500
ROST icon
1247
Ross Stores
ROST
$81.1B
$227K ﹤0.01%
6,032
-2,294
-28% -$79.8K
FEIC
1248
DELISTED
FEI COMPANY
FEIC
$227K ﹤0.01%
+3,010
New +$253K
IONS icon
1249
Ionis Pharmaceuticals
IONS
$9.06B
$225K ﹤0.01%
+5,812
New +$206K
SGOL icon
1250
abrdn Physical Gold Shares ETF
SGOL
$7.22B
$225K ﹤0.01%
19,000

Similar funds

William Blair & Company's Q3 2014 Portfolio in Review

As of Q3 2014, William Blair & Company held 2,314 positions worth $58.5B, down 4.5% from $61.2B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.

William Blair & Company's Q3 2014 filing shows 217 new, 799 increased, 860 reduced and 188 closed positions. Its largest new stake was Alibaba: 1,144,057 shares worth $102M. The largest sale was TSMC, an estimated $196M.

By sector, the portfolio is most concentrated in Industrials at 8.4% of assets, up from 8.2% a quarter earlier, followed by Healthcare and Technology.

  • William Blair & Company's largest Q3 2014 buy was Alibaba: 1,144,057 shares worth $102M.
  • William Blair & Company added most to Teva Pharmaceuticals in Q3 2014, an estimated $246M increase.
  • William Blair & Company's biggest Q3 2014 reduction was TSMC, cutting an estimated $196M.
  • William Blair & Company fully exited ROCKWOOD HLDGS INC in Q3 2014, selling an estimated $59.6M.
  • William Blair & Company's ten largest holdings make up 6.8% of its $58.5B portfolio in Q3 2014.
  • William Blair & Company opened 217 new positions and closed 188 in Q3 2014.
  • William Blair & Company's portfolio value fell 4.5% quarter-over-quarter to $58.5B.

Based on William Blair & Company's 13F filing for Q3 2014, filed 4 Nov 2014.